EileenOBrien:
It’s that time again: time to talk biopharma marketing & sm during the #socpharm tweetchat. Say hello tweeps! #hcmktg #epharma
EileenOBrien:
We’ll assume that all tweets within #socpharm are your own and not your employers (unless you specifically declare them)
EileenOBrien:
T1: @whydotpharma blogged: Why Pharma engagement on Twitter matters http://t.co/F6bNiazb What to you think? #socpharm #hcmktg
EileenOBrien:
T1: Do you agree “Twitter is the new answer to your old loyalty & outreach program”? #socpharm
FDALawyers:
Is it just me or do the numbers not necessarily prove the facts they assert to prove? #socpharm
EileenOBrien:
@FDALawyers: Welcome! I was wondering if everyone was holiday shopping
#socpharm
FDALawyers:
Thanks @EileenOBrien: . Happy to be here
#socpharm
CiaranSB:
Ciaran is joining – sorry to be late. Read and reread Pharma Engagement on Twitter Matters bit.ly/tKVWWn with great interest #socpharm
FDALawyers:
FYI: Physician Payment sunshine act regs just got released a few hours ago
#socpharm
FDALawyers:
Welcome @ciaranSB #socpharm
EileenOBrien:
@FDALawyers: Oooooh, we should talk about that second. #socpharm
lsk204:
#socpharm Lisa here, sorry I’m late!
FDALawyers:
FYI to @EileenOBrien: and @ciaransb … I am REALLY BORING and enjoy regs and the like…. beware in advance
#socpharm
FDALawyers:
Hey Lisa #socpharm
EileenOBrien:
@FDALawyers: I had a hard time reading the chart details but thesis makes sense: engage more w/ur audience & they’ll share ur info #socpharm
EileenOBrien:
@FDALawyers: LOL, are you kidding we get excited talking about pharma marketing! #socpharm
crshorizon:
Hi All – Happy Holidays! #socpharm
DaphneLeigh:
Hi, all…lurking around this evening. #socpharm
EileenOBrien:
@DaphneLeigh: @crshorizon: Hey guys! We’re just getting going. #socpharm
EileenOBrien:
T1: Do you agree with “Twitter is the new answer to your old loyalty & outreach program”? #socpharm
CiaranSB:
LOL I like it cause FDA may be mentioned and I get to drink…RT @FDALawyers: : .. I am REALLY BORING and enjoy regs and the like.. #socpharm
EileenOBrien:
That’s right, for those new to the #socpharm chat we take a sip everytime the FDA is mentioned & chug when FDA official called out by name!
FDALawyers:
@EileenOBrien: I havent had a chance to read the Regs yet. I will be talking about it on #rxprm on Jan 2nd at 9pm EST #socpharm
DaphneLeigh:
@EileenOBrien: No to T1: Twitter is another channel, not an answer. #socpharm
FDALawyers:
@CiaranSB: Is it the latest drinking game? (Mention FDA take a shot?) #socpharm
lsk204:
@EileenOBrien: I like that article, think it would be worth measuring engagement in depth more (T1) #socpharm
CiaranSB:
T1: IMO: don’t think it’s THE new answer – but certainly should be in the mix #socpharm
EileenOBrien:
@lsk204: Agree, hope it encourages pharma to use Twitter to communicate rather than push press releases, more value. #socpharm
FDALawyers:
@EileenOBrien: My concern was more: How do you measure “reach”? #socpharm
EileenOBrien:
@FDALawyers: Whats #rxprm? #socpharm
EileenOBrien:
@DaphneLeigh: And I’m not sure that 140 characters give you the ability to do a loyalty program justice. Perhaps outreach. #socpharm
DaphneLeigh:
@FDALawyers: Anything different on the released regs, vs. the pre-released regs?
#socpharm
crshorizon:
@EileenOBrien: No doubt Twitter’s important for outreach but doesn’t necessarily translate to loyalty – but it’s part of loyalty. #socpharm
FDALawyers:
@eileenobrien Sorry, not trying to x-promote. Its my chat first mon q month @ 9pm on Rx mktg Regs and pharma compliance #socpharm
CiaranSB:
RT @EileenOBrien: : @DaphneLeigh: I’m not sure that 140 characters give the ability to do loyalty program justice. Perhaps outreach. #socpharm
EileenOBrien:
Let’s ask @whydotpharma re Twitter post: RT @FDALawyers: : My concern was more: How do you measure “reach”? #socpharm
FDALawyers:
@EileenOBrien: Trying to decide whether should switch from #rxprm (rx promotion) to #rxcom (rx compliance/ communication) #socpharm
FDALawyers:
@EileenOBrien: Standing by….
#socpharm
EileenOBrien:
We live to promote MT @FDALawyers: : not trying to x-promote. chat 1st mon q month @9pm on Rx mktg Regs&pharma compliance #socpharm
DaphneLeigh:
@FDALawyers: So…you have any thoughts on the Sebelius-FDA debacle? (kinda off-topic, I know) #socpharm
PepoCardenasT:
RT @FDALawyers: : Is it just me or do the numbers not necessarily prove the facts they assert to prove? #socpharm
FDALawyers:
@DaphneLeigh: Sorry. Havent had a chance to read closely yet. Will have a response for you in 3 weeks? (Or sooner…) #socpharm
EileenOBrien:
@FDALawyers: I don’t know, they are both nice & short. #socpharm
DaphneLeigh:
@EileenOBrien: @FDALawyers: @9pm Y’all are shameless
#socpharm
FDALawyers:
@DaphneLeigh: I feel like a 3rd grader….oooooooooooooo (pointing and comparing and instigating) #socpharm
FDALawyers:
@DaphneLeigh: I feel like a 3rd grader….oooooooooooooo (pointing and comparing and instigating) #socpharm
soulflsepulcher:
RT @RtrsIN_Health Drugmakers get more time to record gifts to doctors http://t.co/8s1PMx59 #hcsm #socpharm
FDALawyers:
@DaphneLeigh: yeah… that
#socpharm
EileenOBrien:
@DaphneLeigh: Yes, let’s talk about that since it was fascinating to see politics take back seat to science! #socpharm
DaphneLeigh:
@FDALawyers: lol…imagine you’ll have an interesting POV on this. #socpharm
EileenOBrien:
For those of you who aren’t familiar: http://t.co/c0b4RQT0 #socpharm
EileenOBrien:
Wait, I meant that the other way – see science take back seat to politics. #socpharm
DaphneLeigh:
@EileenOBrien: Yup…bottom line: Not cool. Other bottom line: I’m parent to a teen
#socpharm
FDALawyers:
@daphneleigh POV yes… interesting (definately)… useful….. thats up for debate #socpharm
EileenOBrien:
@FDALawyers: Does this happen frequently? #socpharm
DaphneLeigh:
@EileenOBrien: It’s okay, I knew what you meant
#socpharm
FDALawyers:
@EileenOBrien: I really hope that we just dont know the whole story. Would suck if science took a back seat. #socpharm
DaphneLeigh:
@FDALawyers: Pretty much, science does indeed seem to have taken a back seat. Scary. @EileenOBrien: #socpharm
FDALawyers:
@EileenOBrien: Having said that: Science must be tempered by what pop is ready 4. Stem cell cloning in 14th century = witchcraft. #socpharm
FDALawyers:
@EileenOBrien: As far as I know, its the first time. #socpharm
DaphneLeigh:
@FDALawyers: @EileenOBrien: Geez, I keep infiltrating myself here. It IS the first time, that’s what’s so disturbing about this. #socpharm
pharmaguy:
RT @soulflsepulcher: RT @RtrsIN_Health Drugmakers get more time to record gifts to doctors http://t.co/BfbCsCib #hcsm #socpharm
DaphneLeigh:
@FDALawyers: @EileenOBrien: And, what’s the real motivation, with elections upcoming and all that. #socpharm
FDALawyers:
@DaphneLeigh: Which is why I hope that there is more to the story than just: science 0, politics 1 #socpharm
EileenOBrien:
@DaphneLeigh: So sad it happened under the Dems too. #socpharm
EileenOBrien:
T3: From @manhattanresearch study, EU consumers want info from websites not FB http://t.co/FSm7mIp4 . Surprising? #socpharm
DaphneLeigh:
@FDALawyers: Yup. Hard to get parents of >11yo to agree to trialing for sake of science, though. #socpharm
DaphneLeigh:
@EileenOBrien: true that. #socpharm
pharmaguy:
@eileenobrien More sad that’s it’s Wo-mano a Wo-mano! #socpharm
EileenOBrien:
T3: I’m surprised in the first place that so many people are interested in engaging w/pharma & health info on FB. #socpharm
FDALawyers:
@DaphneLeigh: Sorry… can you help me with context there? #socpharm
shwen:
#hcsm #SocPharm Any1 know the survival or success rate of radio therapy Tx for inoperable metastatic brain tumor? 4 my cuz’s BFF
TY!
FDALawyers:
@pharmaguy: Really? To me that was sort of irrelevant. I saw this as one agency against momma agency. #socpharm
DaphneLeigh:
@FDALawyers: Ah, that was Sebelius rationale…no proof that the OTC w/b safe for >11yo group. #socpharm
lsk204:
#socpharm @EileenOBrien: Yes, facebook doesn’t seem like the most “legit” place to be getting medical advice (T3)
FDALawyers:
@DaphneLeigh: Oh that.. yeah… thanks
#socpharm
FDALawyers:
@DaphneLeigh: Oh that.. yeah… thanks
#socpharm
FDALawyers:
@EileenOBrien: Not at all. I like my friends. But most shouldnt be telling me how to diagnose myself. Thats what experts are 4. #socpharm
EileenOBrien:
I think people forget that FB owns the data & everything is so open! The concept of privacy is certainly different nowadays. #socpharm
DaphneLeigh:
@FDALawyers: You bet
#socpharm
FDALawyers:
@EileenOBrien: Website often has expert help. Facebook great for crowdsourcing. #socpharm
DaphneLeigh:
@EileenOBrien: As in, there is no privacy
#socpharm
pharmaguy:
@fdalawyers Sorry, I was being flippant. It’s leading to renewed calls for FDA to be independent of HHS. http://t.co/MHqCRDEH #socpharm
DaphneLeigh:
@FDALawyers: Experts don’t always know bigger picture, sometimes friends and family offer something experts don’t. #socpharm
EileenOBrien:
T4: Roche & Pfizer Turkey created Google+ pages: http://t.co/bQ8qVerF Good move? Expect more companies to jump in? #socpharm
crshorizon:
@EileenOBrien: Makes sense – more comprehensive info in 1 spot; may use FB to vet diag/trtmt options, etc. w/peers & friends #socpharm
FDALawyers:
@pharmaguy: I hope its not as big a deal as its made out to be. FDA = science. HHS takes health into account. Diff. in judgment? #socpharm
FDALawyers:
@DaphneLeigh: Agreed. 4 facts, experts better. For subjective/emotional/experience, fam/friends better. #socpharm
FDALawyers:
@EileenOBrien: Staking a claim. Issue is, should they be doing that? Is that considered DTC?
#socpharm
EileenOBrien:
Like the idea that @skoko said they were “reserving the space” until they figure out when/if how to use it. #socpharm
EileenOBrien:
@FDALawyers: All they’ve done so far is put company logo, no brand info so not DTC. #socpharm
pharmaguy:
@daphneleigh Not a safety issue per se. Sebelius said girls under 17 wouldn’t understand the dosing regimen. #socpharm
DaphneLeigh:
@pharmaguy: Actually, I believe she said girls under 11, and that it was a possible safety issue. #socpharm
EileenOBrien:
T4: The Pfizer Turkey page seems to be gone? #socpharm
FDALawyers:
@EileenOBrien: Fun when it was merck v. merck fighting over reserved space. http://t.co/yFfgKrBT #socpharm
FDALawyers:
@pharmaguy: Isnt that a safety issue? #socpharm
FDALawyers:
@pharmaguy: Isnt that a safety issue? #socpharm
EileenOBrien:
@FDALawyers: I know we’ve come a LONG way when 2 pharma companies are suing over a Facebook page! #socpharm
FDALawyers:
@EileenOBrien: … yet
#socpharm
DaphneLeigh:
@pharmaguy: See this: http://t.co/QUH3aLYu #socpharm
EileenOBrien:
Makes sense that companies would want to avoid any confusion moving forward & also fake pages fooling people. #socpharm
pharmaguy:
@eileenobrien There should be a way to reserve the name space w/o having another deserted, do nothing site. #socpharm
whistle39:
RT @pharmaguy: : RT @soulflsepulcher: RT @RtrsIN_Health Drugmakers get more time to record gifts to doctors http://t.co/BfbCsCib #hcsm #socpharm
lsk204:
FDALawyers: @DaphneLeigh: I can see that, I think people may prefer to see how others weigh efficacy and side effects of a drug #socpharm
EileenOBrien:
Agree! RT @pharmaguy: : @eileenobrien There should be a way to reserve the name space w/o having another deserted, do nothing site. #socpharm
crshorizon:
@EileenOBrien: so when’s FB+ going to debut
#socpharm
EileenOBrien:
Last topic: any predictions for 2012? #socpharm
FDALawyers:
@crshorizon: Once google buys FB
#socpharm
DaphneLeigh:
@EileenOBrien: You mean, like the Letterman top 10
#socpharm
FDALawyers:
@EileenOBrien: More fines/ jail terms/ lawsuits #socpharm
EileenOBrien:
But funnier
RT @DaphneLeigh: : @EileenOBrien: You mean, like the Letterman top 10
#socpharm
EileenOBrien:
@FDALawyers: Does this mean more wrongdoing or more people getting caught? #socpharm
pharmaguy:
@daphneleigh Read Sebelius’ actual words here: http://t.co/MnUW2tzi Obama just citing an easier to understand bogus rationale. #socpharm
FDALawyers:
@EileenOBrien: … neither: More people looking
(I had some convos with friends in the govt.) #socpharm
FDALawyers:
@EileenOBrien: Sorry, I was wrong. I meant, hopefully not more wrongdoing.
#socpharm
EileenOBrien:
@FDALawyers: So more people getting caught. #socpharm
pharmaguy:
@eileenobrien Prediction for 2012: There will be more embarrassing pharma SM faux pas, IMHO. #socpharm
lsk204:
@FDALawyers: More people getting in trouble from social media endeavors assumes FDA will come up with more hard and fast rules #socpharm
DaphneLeigh:
@EileenOBrien: My prediction: There will be 17,000 more mobile apps added to mix that no one is really using. #socpharm
EileenOBrien:
@pharmaguy: More people trying the social media space I guess will equal more mistakes. #socpharm
FDALawyers:
@EileenOBrien: you got me
I guess some from column A and some from column B. Becoz C is looking more often and harder? #socpharm
EileenOBrien:
@DaphneLeigh: That is truly funny. #socpharm
DaphneLeigh:
@pharmaguy: Got it, will read. Fascinating topic. #socpharm
CalBjr:
RT @EileenOBrien: : Out of 240 brand sites reviewed only 1/5 have any African American imagery: http://t.co/sOIZVWEB. #socpharm #hcmktg # …
FDALawyers:
@lsk204: I wasnt restricting to SM or to the FDA. But ur point is well made. #socpharm
DaphneLeigh:
@EileenOBrien: You said you wanted funny
#socpharm
FDALawyers:
@EileenOBrien: A mistake is a sign you are trying. Cant fault that
#socpharm
FDALawyers:
RT @DaphneLeigh: : @EileenOBrien: My prediction: There will be 17,000 more mobile apps added to mix that no one is really using. #socpharm
EileenOBrien:
My prediction: as more companies use social media effectively & case studies are shared, even more companies will take part. #socpharm
EileenOBrien:
I know we’ve been saying this for 3 years, but 2012 will really be the year of mobile! #socpharm
DaphneLeigh:
@EileenOBrien: mobile, schmobile
#socpharm
FDALawyers:
@CalBjr: I demand some Indian imagery. I demand some pictures of the Taj, snake charmers and slum dog millionaire.
#socpharm
FDALawyers:
@EileenOBrien: I think every year is the year of mobile. The question is when does the decade of stationary end? #socpharm
RobRenjilian:
How about QR codes taking off a bit more? (I hear such mixed information) #socpharm
lsk204:
@EileenOBrien: Agreed, I think mobile will only grow, esp. since it’s getting cheaper and cheaper to own a mobile device. #socpharm
CalBjr:
@lsk204: @fdalawyers no question guidelines clearly have to be in the works. #socpharm hello everyone
FDALawyers:
(Is stationary a device type?) #socpharm
EileenOBrien:
@RobRenjilian: Hey there Rob!! Yes, some people are big fans of QR codes . #socpharm
FDALawyers:
@RobRenjilian: Personally, QR Codes were DOA. Requires too much interactivity. #socpharm
lsk204:
@FDALawyers: Soon stationary will be more expensive than a smart phone #socpharm
pharmaguy:
@calbjr What % of drug sales in U.S. is attributable to treating African Americans? That would be a more interesting factoid. #socpharm
FDALawyers:
@lsk204: To quote my english accent challenged countrymen: Egg-jhactlie #socpharm
DaphneLeigh:
Gotta split and walk the dog, thanks @EileenOBrien: @FDALawyers: et al. for convo tonight! #socpharm
CalBjr:
#socpharm any additional thoughts on how Siri (apple) will impact mobile health?
EileenOBrien:
@lsk204: True people in developing nations are “leapfrogging” over owning laptops/desktops & go right to smartphone. #socpharm
RobRenjilian:
@FDALawyers: Yup…That’s one side that comes up often (and agree, BTW) #socpharm
CiaranSB:
RT @DaphneLeigh: : @EileenOBrien: My prediction: There will be 17,000 more mobile apps added to mix that no one is really using. #socpharm
FDALawyers:
@DaphneLeigh: Thank you for talking to me. I often get put in the corner.
— and nobody puts baby in a corner. #socpharm
pharmaguy:
@fdalawyers My new business cards use ONLY QR codes! If you can’y decode, hit the road! #socpharm
FDALawyers:
@CalBjr: Siri will “decide” what is important. Google gives choices. Siri gives answers. Answers can be biased. #socpharm
DaphneLeigh:
@FDALawyers: I dunno…just don’t see you in a corner, ya know
#socpharm
FDALawyers:
@pharmaguy: 4 me. Easier to hit the road. Besides, I can find and harass you here
#socpharm
EileenOBrien:
There’s already been controversy over Siri sent info for pregnancy ctr to request for termination: http://t.co/G0LPwGlk #socpharm
FDALawyers:
@DaphneLeigh: Well.. it happens.. often includes villagers with pitchforks #socpharm
MDNewsLinks:
How to become a Twitter chat star—8 easy ways http://t.co/pvaeiiJZ #hcsm #hcmktg #socpharm #hcpr
FDALawyers:
@EileenOBrien: Yup. Answers may not always include the info you want. #socpharm
FDALawyers:
@EileenOBrien: The internet was all about stumblling across info. What happens if you get an answer, but no context. Thats siri. #socpharm
erohealth:
@EileenOBrien: I predict in 2012 that DDMAC or whatever they are calling themselves will not provide SM guidance
#socpharm
EileenOBrien:
Our time is up. Thanks for another interesting #socpharm convo! We’ll be breaking for next 2 weeks for holidays. See u 1/5!
EileenOBrien:
@erohealth I hear that! #socpharm
lsk204:
@EileenOBrien: @FDALawyers: Doesn’t surprise me, Apple has always felt like more of a “Big Brother” than Google. #socpharm
FDALawyers:
@erohealth RIP DDMAC. All hail OPDP. #socpharm
EileenOBrien:
Wait, I meant see you FDALawyers: @EileenOBrien: Did you hear why? #socpharm
EileenOBrien:
That just reminds me of “down with OPP” too much. RT @FDALawyers: : @erohealth RIP DDMAC. All hail OPDP. #socpharm
EileenOBrien:
@FDALawyers: no, what was the reason? #socpharm
erohealth:
RT @EileenOBrien: : That just reminds me of “down with OPP” too much. RT @FDALawyers: : @erohealth RIP DDMAC. All hail OPDP. #socpharm
FDALawyers:
@EileenOBrien: Something I hinted at in a few chats/talks I have given. Pending lawsuits/ IMS v. Sorrell #socpharm
CalBjr:
1 in 4 apps downloaded & then deleted #DigPharm #socpharm
FDALawyers:
@erohealth yeah.. you know me
#socpharm
EileenOBrien:
Everyone have a wonderful holiday season! Look forward to coming back rejuvenated in January. #socpharm
FDALawyers:
@EileenOBrien: Join us on Jan 2 for #rxprm @9pm. Will chat abt the CMS regs on sunshine act, and maybe even delay in SM guidance #socpharm
lsk204:
Thanks #socpharm ers, thanks for hosting @EileenOBrien:
EileenOBrien:
Will do! MT @FDALawyers: : Join us Jan 2 for #rxprm @9pm. Will chat abt CMS regs on sunshine act, & maybe even delay in SM guidance #socpharm
FDALawyers:
@EileenOBrien: Thanks for the great moderation & keeping me inline. I need to be slapped arnd often. Thats wht the wife says. #socpharm
EileenOBrien:
@FDALawyers: I don’t believe in hitting
I’m a lover not a fighter. Thanks for sharing your insights. #socpharm


Transcript from Wed night's #socpharm tweetchat is now up: http://t.co/sHrskdoZ Taking a 2 week holiday break, see you Jan 4, 2012!
RT @EileenOBrien: Transcript from Wed night's #socpharm tweetchat. http://t.co/EFYsb4h7 Taking a 2 week holiday break, see you Jan 4, 2012!